Amar Bansal

NPI 1093032112ActiveIndividual· Internal Medicine, Nephrology· Pittsburgh, PA

Internal Medicine, Nephrology in Pittsburgh, Pennsylvania, trained at New York University School of Medicine (class of 2010). Their prescriptions cost Medicare Part D more than their services did: $182,535 for 542 claims, against $27,355 paid for services in 2024. Otsuka America Pharmaceutical, Inc. reported $81.21 in payments in 2025, mostly food and beverage.

Overview

NPI	1093032112
Status	Active
Entity type	Individual
Sole proprietor	No
NPI issued	Apr 29, 2010
Last updated in NPPES	May 24, 2021
Certified by provider	Mar 12, 2020

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Nephrology Primary	207RN0300X	MD446615	PA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026	No match	—
New York OMIG · Nov 10, 2026	No match	—
Ohio Medicaid · Nov 10, 2026	No match	—
Pennsylvania Medicheck · Nov 10, 2026	No match	—
Washington HCA · Nov 10, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Nephrology (PA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	141
Services billed	385 across 14 procedure codes
Paid by Medicare	$27,355

Part D prescriptions in 2024

Prescriptions (claims)	542 · 1,149 30-day fills
Patients	112
Total drug cost	$182,535
Generic share	76% of claims

Medicare sources and data years

Education and affiliations

Medical school	New York University School of Medicine
Graduation year	2010
Medicare specialty	Nephrology
Secondary specialties	Hospice/Palliative Care, Internal Medicine
Telehealth	Offers telehealth